Last update :
28/04/2024
Anticancer drug   Mitoxantrone dihydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bluxantron Ecuador
Bresnix Mexico
Ebexantron Austria
Elsep France
Formyxan Colombia, Ecuador, Mexico
Genefadrone Greece
Mitoxgen Argentina
Neotalem Mexico
Novantron Austria, Germany, Switzerland
Novantrone Belgium, Chile, Denmark, France, Greece, Hungary, Ireland, Italy, Luxembourg, Malaysia, Morocco, New Zealand, Norway, Republic of South Africa, Romania, Slovenia, Spain, Sweden, Thailand, Turkey, United Arab Emirates, United States of America
Onkotrone Australia, Germany, Great Britain, Italy, Luxembourg, Romania
Ralenova Germany
Refador Hungary
Santrone Egypt, Malaysia
Strimax Spain
Xantrosin Belgium
Stability of mixtures   Injection   Stability of mixtures : Mitoxantrone dihydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Not specified None 1 mg/ml
Injection   Mitoxantrone dihydrochloride   
Injection   Etoposide 10 mg/ml
25°C
22 Hour
Protect from light 1730
Level of evidence D
Not specified None 0,05 mg/ml
Injection   Mitoxantrone dihydrochloride   
Injection   Etoposide 0,5 mg/ml
25°C
22 Hour
Protect from light 1730
Level of evidence D

  Mentions Légales